Your browser doesn't support javascript.
loading
Predictive factors of recurrence after omalizumab cessation in the elderly with urticaria: A real-life study.
Oztop, Nida; Demir, Semra; Unal, Derya; Beyaz, Sengul; Terzioglu, Kadriye; Olgac, Muge; Gelincik, Asli.
Afiliación
  • Oztop N; From the Division of Immunology and Allergic Diseases, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
  • Demir S; From the Division of Immunology and Allergic Diseases, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
  • Unal D; From the Division of Immunology and Allergic Diseases, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
  • Beyaz S; Department of Adult Allergy and Clinical Immunology, Ankara City Hospital, Ankara, Turkey.
  • Terzioglu K; Department of Adult Allergy and Clinical Immunology, SBÜ Kartal Education and Training Hospital, Istanbul, Turkey, and.
  • Olgac M; Department of Adult Allergy and Clinical Immunology, SBU Sisli Hamidiye Etfal Education and Training Hospital, Istanbul, Turkey.
  • Gelincik A; From the Division of Immunology and Allergic Diseases, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Allergy Asthma Proc ; 43(6): 519-528, 2022 11 01.
Article en En | MEDLINE | ID: mdl-36335414

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Urticaria / Antialérgicos / Urticaria Crónica Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Humans / Middle aged Idioma: En Revista: Allergy Asthma Proc Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Urticaria / Antialérgicos / Urticaria Crónica Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Humans / Middle aged Idioma: En Revista: Allergy Asthma Proc Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Estados Unidos